A major advance in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This crucial malignant protector protein is frequently disabled in several types of tumors, leading uncontrolled https://hindibookmark.com/story24041636/mini-antibodies-restore-the-p53-protein-the-promising-pathway-for-tumor-treatment